These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 796485)

  • 21. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
    Ohkawa M; Hirano S; Nakashima T; Tokunaga S; Motoi I; Kuroda K; Nakamura T; Iwasa Y; Tajika E; Sakai A; Haginaka T; Kanda S; Kato M; Hasegawa M; Mikawa I; Ikeda A; Shoda R; Ejiri S; Takemae K; Kojima A; Nakajima S; Miyagi T; Ohtaki M; Kitagawa K; Kameda K; Taya T; Okumura R; Shimada K; Kobayashi T; Nango C; Okasho A; Fujita Y; Miyazaki K; Tsukahara K; Kawaguchi S; Tanaka T; Ueno K; Watanabe K
    Jpn J Antibiot; 1983 Jan; 36(1):129-49. PubMed ID: 6341653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Review [new antibiotics series I]: cefuroxime (author's transl)].
    Nakagawa K
    Jpn J Antibiot; 1982 Feb; 35(2):283-95. PubMed ID: 7045446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of cephacetrile (Celtol) for respiratory infections (author's transl)].
    Horiuchi N; Oyakawa Y; Oka R; Fujiwara T
    Jpn J Antibiot; 1980 Oct; 33(10):1145-55. PubMed ID: 7206219
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience with ceftezole (author's transl)].
    Ishikawa K
    Jpn J Antibiot; 1978 Nov; 31(11):633-5. PubMed ID: 731859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the clinical effect of ceftezole (Falomesin 'Chugai') in respiratory- and urinary-tract infections (author's transl)].
    Arai S; Takishima T; Kosaka S; Kanazawa T; Takahashi H; Hamajima A; Nishimura H; Yoshida T; Tamura T; Usui Y; Takasugi R; Iwabuchi T; Ise T; Ishii M; Tadokoro K; Matsumoto N; Sato S; Saito K; Sato T; Kudo K; Mori S; Shimanuki K; Ito K; Ishihara T; Maeda T; Tsuiki K; Takahashi K; Kimura H; Saito K; Ishikawa H; Kanehara A
    Jpn J Antibiot; 1978 Nov; 31(11):625-32. PubMed ID: 731858
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental and clinical studies on cefoperazone (author's transl)].
    Toyonaga Y; Kurosu Y; Yoshikawa H; Kumagai K; Takahashi T; Hori M
    Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laboratory and clinical studies of cefoperazone in children (author's transl)].
    Iwai N; Sasaki A; Miyazu M; Osuga T; Inokuma K
    Jpn J Antibiot; 1980 Sep; 33(9):871-90. PubMed ID: 6452536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative double-blind study of cefroxadine and cephalexin in the treatment of complicated urinary tract infection].
    Kamidono S; Harada M; Ishigami J; Takasaki N; Miyazaki S; Furusawa T; Mizunoe Y; Ito K; Momose S; Nakamuta S
    Jpn J Antibiot; 1983 Sep; 36(9):2571-94. PubMed ID: 6361324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
    Oikawa M; Watanabe I
    Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteriological and clinical studies on cefotaxime in obstetrics and gynecology (author's transl)].
    Ninomiya K; Hasegawa Y; Hamatani K; Nishio T
    Jpn J Antibiot; 1981 Apr; 34(4):507-14. PubMed ID: 6270399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experience in the management of urinary tract infections with cephazolin].
    Nuri M; Peters HJ
    Adv Clin Pharmacol; 1974; 8():118-22. PubMed ID: 4468726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bacteriological and clinical studies of cefoxitin with special reference to anaerobic infections in the patients of abdominal surgery (author's transl)].
    Karaki K; Katada M; Kawaguchi H; Sasaki K; Kobayashi H; Inoue I; Kawai F; Uehara K; Sasaki H; Uegaki K; Deguchi K
    Jpn J Antibiot; 1981 Sep; 34(9):1320-34. PubMed ID: 7328755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.